Skip to content

Sickledex 217661

by Streck

Sickledex 217661 is a Class II device made by Streck, cleared under FDA 510(k) K023656 on 30 Dec 2002 and listed in FDA GUDID since 19 Sep 2016 (UDI-DI 00844509002024), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

510(k) K023656

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00844509002024 UDI-DI Date19 Sep 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK023656 Date30 Dec 2002DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K023656 decided 30 Dec 2002 Active
  • FDA GUDID UDI-DI 00844509002024 listed 19 Sep 2016 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K023656
  2. Listed FDA GUDID 00844509002024

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Sickledex
Generic name
Haemoglobin S (HbS) IVD, control
Model / Ref / Catalog
217661
Description
A qualitative solubility test kit used to detect the presence of sickling hemoglobins in human blood or sickle cell control material. Contains 12 tests.
Primary DI / UDI-DI
00844509002024
510(k) Number
FDA product code
GHM
GMDN term
Haemoglobin S (HbS) IVD, control
Device class
Class II
Regulation number
864.7825
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code GHM (Test, Sickle Cell).

Other devices from Streck

See all devices from Streck →

Properties

  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (12, all answered No)